Block Admission to Trading

Summary by AI ^BETAClose X

The Unite Group PLC has announced the block admission to trading of 105,816 ordinary shares of 25p each on the London Stock Exchange's Main Market. This admission includes 84,912 shares issued under the Restricted Share Plan and 20,904 shares under the Performance Share Plan, bringing the total number of ordinary shares in issue to 519,257,825. These new shares are fully fungible with existing ordinary shares.

Disclaimer*

Unite Group PLC (The)

08 June 2026

THE UNITE GROUP PLC (the "Company")

8 June 2026

BLOCK ADMISSION TO TRADING

In accordance with The Public Offers and Admissions to Trading Regulations 2024 (POATRs) PRM 1.6.4R, the Company notifies that 105,816 ordinary shares of 25p each have been admitted to trading on the London Stock Exchange, as follows:

1	Details of the issuer
a)	Name	The Unite Group plc
b)	LEI	213800BBUUWVDH9YI827
2	Details of the transferable securities admitted to trading
a)	Name, type and identification code	Ordinary shares of 25 each ISIN: GB0006928617
b)	Regulated market	London Stock Exchange - Main Market
c)	Number of further securities admitted	84,912 ordinary shares in respect of the Restricted Share Plan (RSP) and 20,904 ordinary shares in respect of the Performance Share Plan (PSP), issued on 17 April 2026
d)	Total number of securities in issue following admission	519,257,825 ordinary shares. No ordinary shares held in treasury
e)	Fungibility	Fully fungible with existing ordinary shares.
3	Admission details
a)	Date(s) of admission	As noted in 2c) above.
b)	Prospectus information	Prospectus: N/A Supplementary: N/A Company's webpage: https://www.unitegroup.com
c)	Coverage of notification	All admissions up to and including 8 June 2026

For further information, please contact:

Unite Group

Christopher Szpojnarowicz, Company Secretary

Tel: +44 117 302 7005

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END